Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

23 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Nitazoxanide Articles

Romark's nitazoxanide boosts SVR of SOC

30 March 2009

Japan stock market week to Feb 23, 2009

2 March 2009

Chugai licenses Japanese rights to Romark's HCV drug nitazoxanide

23 February 2009

Nitazoxanide plus SOC achieves SVR24 of 79%

5 May 2008

Romark's Alinia now on sales in USA

24 March 2003

HIV Advances Lead To Unimed Setback

11 May 1998

Unimed's NTZ Gets Priority Review

9 March 1998

BioChem Pipeline Products To Advance In 1997

13 January 1997

Nitazoxanide Ph II Study Enrollment Complete

25 March 1996

Unimed's antiparasitic agent NTZ: Phase III news

15 January 1996

Unimed: nitazoxanide trials

25 September 1995

Showing 1-11 of 11 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS